National coverage with top health systems and three of the four top commercial labs.
MMIT’s Lab Data for Commercial Targeting provides a proactive, economic, precise, and comprehensive solution to help manufacturers promote their therapies to specific providers using lab test results before a diagnosis or prescribing decision is made.
Get your commercial team in front of providers, before a diagnosis is made or a medication is prescribed.
National coverage with top health systems and three of the four top commercial labs.
MMIT's Lab-Based Alerts provide real-time precision targeting for sales and marketing teams to enable personal and non-personal promotion execution across high-value HCPs and hard-to-reach patient populations.
Identify
Physicians who are ordering select diagnostic tests so you can proactively target them with brand promotions.
Deploy
Field sales teams to prioritized physicians based on weekly testing alerts.
Correlate
Patient incidence rates to testing rates by ZIP code to identify physicians who require education on relevant testing.
Track
All providers (NPIs) who are testing and diagnosing positive patients.
MMIT’s real-world data assets are powered by NorstellaLinQ, the first and only fully integrated data asset combining real-world data and Norstella’s proprietary intelligence from the most trusted brands in the industry – Citeline, Evaluate, MMIT, Panalgo and The Dedham Group. It combines data including open and closed claims, lab results, and electronic medical records with Norstella’s proprietary forecasting, clinical, regulatory, payer, and commercial intelligence data.
Combining our Claims Data (refreshed weekly) and Lab Data (refreshed daily), we provide field sales teams and their programmatic advertising agency partners with aggregated alerts for proactive physician targeting and patient identification before a prescribing decision.
MMIT's medical and pharmacy data allow companies to define a patient cohort, including date of diagnosis, time to treat, cost of care, treatment team and length of treatment.
MMIT's Lab Data tracks critical events such as biomarkers and targeted therapies, disease progression (cancer antigen testing), and adverse event management.
MMIT’s Patient Access Analytics solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
One of the first steps in your therapy’s commercialization journey should be to identify high-value HCPs who can help guide valuation, messaging and more.